Mackensen A, Haanen JBAG, Koenecke C, Alsdorf W, et al. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat Med 2023 Oct 23. doi: 10.1038/s41591-023-02612.
PMID: 37872225